PAK Biosolutions, Inc.

Vienna, VA

UEI
D2BBLN4AKAW5
CAGE
8ET69
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
8607 Westwood Center Dr Suite 560, Vienna, VA 22182, USA
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Industrials
  2. Capital Goods
  3. Industrial Conglomerates
  4. Industrials & Manufacturing
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $451,450
FY2023 $25,731

Contract awards

Grant awards

Similar vendors

About the company

PAK Biosolutions, Inc. is a woman-owned small business and manufacturer of biopharmaceutical equipment and solutions, specializing in continuous manufacturing instruments and integrated bioprocessing purification systems. The company focuses on developing advanced technological solutions for pharmaceutical process development, with a particular emphasis on creating innovative continuous manufacturing equipment that can accelerate drug development timelines and reduce manufacturing costs. As a registered federal contractor and grant recipient, PAK Biosolutions provides specialized scientific instrumentation and equipment primarily to civilian federal agencies in the healthcare and biotechnology sectors.

Through federal contract awards, PAK Biosolutions has consistently worked with the Food and Drug Administration (FDA), securing multiple purchase order contracts for sophisticated scientific equipment. These contracts, which have been designated as small business set-asides, include procurement of continuous manufacturing instruments such as the PAK System continuous manufacturing instrument, valued at $573,760, and an Integrated Continuous Purification System valued at $504,522. The company has also received smaller contract awards for parts and components, demonstrating its ability to provide comprehensive solutions across different scale and complexity levels. Each contract has involved firm-fixed price arrangements, with performance locations primarily in Virginia and Maryland, and contract periods ranging from several months to multiple years.

On the grant side, PAK Biosolutions has received funding from the National Center for Advancing Translational Sciences, a branch of the National Institutes of Health, to develop innovative laboratory-scale continuous bioprocessing technologies. Specifically, their recent grant award (R43TR003975) focuses on developing a "Micro PAK" system, a laboratory-scale version of their existing manufacturing system designed to enable process development scientists to efficiently develop continuous biopharmaceutical manufacturing processes. The grant, awarded in June 2022 with an ultimate completion date of June 2025, aims to create a prototype capable of running a continuous process from initial capture through final drug substance production. The project seeks to address current limitations in batch manufacturing by providing a scaled-down continuous system that can help optimize processes and potentially reduce manufacturing costs in the biopharmaceutical industry.

Quick answers

Is PAK Biosolutions, Inc. registered in SAM.gov?

Yes. PAK Biosolutions, Inc.'s SAM.gov registration is active through September 1, 2027.

What is PAK Biosolutions, Inc.'s CAGE code?

PAK Biosolutions, Inc.'s CAGE code is 8ET69, and its Unique Entity ID (UEI) is D2BBLN4AKAW5.

How much has PAK Biosolutions, Inc. received in federal contracts?

Federal contracts obligated $477,181 to PAK Biosolutions, Inc. in fiscal years 2023 through 2027.

What is PAK Biosolutions, Inc.'s most recent federal award?

PAK Biosolutions, Inc.'s most recent federal contract award is Procurement of one (1) each PAK system continuous manufacturing instrument (75F40124P00300), from Food and Drug Administration, on July 12, 2024.

On GovTribe

See PAK Biosolutions, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe